Tremendous strides have been made in developing positron emission tomography (PET) radioligands for Aβ amyloid plaques and tau tangles-AD neuropathological hallmarks, magnetic resonance imaging (MRI) methods for brain structural and vascular lesions in living individuals for AD and ADRD detections. This evidence concerns the gene MAPT and Alzheimer disease.